Larvol Launches AI-Powered Cancer Data Platform During ASCO 2020
The Larvol Group on Monday announced the launch of Veri, their new decision support and competitive intelligence tool during the 2020 ASCO Annual Meeting.
Pharmaceuticals, Biotechnology and Life Sciences
The Larvol Group on Monday announced the launch of Veri, their new decision support and competitive intelligence tool during the 2020 ASCO Annual Meeting.
The FDA is working to address the coronavirus disease (COVID-19) outbreak and keep you and your family informed on the latest developments. Here are answers to some frequently asked questions from consumers about testing:
BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will participate in a fireside chat during the virtual Goldman…
Bioparticle-based delivery system offers potential as a coronavirus therapy LOS ANGELES–(BUSINESS WIRE)–An emerging company developing biotechnology invented at UCLA is…
Mylan is potentially getting access to 14 indications after approval, as first neurotoxin formulation to be developed as a potential biosimilar product to BOTOX.
BETHESDA, Md. & AUSTIN, Texas–(BUSINESS WIRE)–Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company focused on…
NEW YORK–(BUSINESS WIRE)–Treadwell Therapeutics, a clinical-stage biotechnology company developing novel therapeutics for highly aggressive cancers, today announced that members of…
-With More than 1.9 Million Square Feet of Greenhouses, Clever Leaves is One of the Largest Cannabis Cultivation and Extraction…
Resolution of middle ear effusion in 56% of OP0201 vs. 38% of placebo patients (p=0.07) Company engages financial advisors to…
— Important Data on Psychosocial Burden of Peanut Allergy on Children and Caregivers Also to be Presented — BRISBANE, Calif.–(BUSINESS…